Diagnostic endomyocardial biopsy pathology - General biopsy considerations, and its use for myocarditis and cardiomyopathy: A review

Canadian Journal of Cardiology

Volumn 18, Issue 1, 2002, Pages 55-65

  Veinot, John P ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Biopsy; Cardiomyopathy; Myocarditis; Myocardium; Pathology; Ventricles

Indexed keywords

ANTHRACYCLINE; CELL ADHESION MOLECULE; IMMUNOSUPPRESSIVE AGENT; VIRUS DNA; VIRUS RNA;

ANALYTICAL ERROR; CARDIOMYOPATHY; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG INTOXICATION; EMBOLISM; GENETIC ANALYSIS; GRAFT REJECTION; HEART ARRHYTHMIA; HEART DILATATION; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART SCINTISCANNING; HEART VENTRICLE TACHYCARDIA; HISTOPATHOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFLAMMATORY INFILTRATE; ISOTOPE LABELING; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR BIOLOGY; MYOCARDITIS; NONHUMAN; PATHOLOGICAL ANATOMY; PATIENT INFORMATION; PATIENT MONITORING; PNEUMOTHORAX; PROGNOSIS; RESTRICTIVE CARDIOMYOPATHY; REVIEW; SAFETY; THORAX PAIN; TISSUE CHARACTERIZATION; TISSUE PREPARATION; VIRUS DETECTION;

BIOPSY, NEEDLE; CANADA; CARDIOMYOPATHIES; DIAGNOSIS, DIFFERENTIAL; ENDOCARDIUM; FEMALE; HUMANS; MALE; MYOCARDITIS; SENSITIVITY AND SPECIFICITY;

EID: 0036123218     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. Endomyocardial biopsy and cardiomyopathy
2. Histological examination of tissues obtained by endomyocardial biopsy
3. Transmission of hepatitis B virus among heart transplant recipients during endomyocardial biopsy procedures
4. Endomyocardial biopsy; An overview
5. Myocarditis: The Dallas criteria
6. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy
7. Myocarditis and idiopathic dilated cardiomyopathy
8. Viral myocarditis; Balance between viral infection and immune response
9. Immune mechanisms of cardiac disease
10. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators
11. Role of right ventricular endomyocardial biopsy in infants with suspected or possible myocarditis
12. Demographic features and prevalence of idiopathic myocarditis in patients undergoing endomyocardial biopsy
13. Enteroviruses and myocarditis
14. Gross and semiquantitative histological findings in mononuclear cell myocarditis causing sudden death, and implications for endomyocardial biopsy
15. Right ventricular endomyocardial biopsy: Clinicopathologic correlates in 100 consecutive patients
16. Diagnosis of active lymphocytic myocarditis by endomyocardial biopsy
17. Brief report: Recognition of acute myocarditis masquerading as acute myocardial infarction
18. Hypersensitivity myocarditis
19. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: Implications for role of sampling error
20. Enteroviral RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy
21. Expression of intercellular adhesion molecule-1 on cardiac myocytes for myocarditis before and during immunosuppressive therapy
22. Immunosuppressive treatment in autoreactive myocarditis-results form a controlled trial
23. Long-term outcome of patients with biopsy-proved myocarditis: Comparison with idiopathic dilated cardiomyopathy
24. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis
25. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies
26. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies
27. Cardiomyopathies
28. Endomyocardial biopsy: A review of the literature
29. Nonpredictive value of fibrosis in dilated cardiomyopathy treated with metoprolol
30. Idiopathic dilated cardiomyopathy
31. Critical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy II: Comparison of histology and clinical/haemodynamic information
32. From myocarditis to cardiomyopathy: Mechanisms of inflammation and cell death: Learning from the past for the future
33. Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy
34. Immunogenetic aspects of dilated cardiomyopathy
35. A prospective case-control study of antibodies to coxsackie B virus in idiopathic dilated cardiomyopathy
36. Mitochondrial DNA deletions in dilated cardiomyopathy: A clinical study employing endomyocardial sampling
37. Dilated cardiomyopathy - New insights into the pathogenesis
38. Abnormal expression of histocompatibility and mitochondrial antigens by cardiac tissue from patients with myocarditis and dilated cardiomyopathy
39. Pathophysiology of cardiomyopathies: Part I. Animal models and humans
40. Dilated cardiomyopathy
41. Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy
42. Molecular pathology of dilated cardiomyopathies
43. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy
44. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction system disease
45. Etiologies of cardiomyopathy and heart failure
46. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement
47. Incidence of myocarditis in peripartum cardiomyopathy
48. The relation of alcoholic myopathy to cardiomyopathy
49. Dilated cardiomyopathy in a Zidovudine-treated AIDS patient
50. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy
51. Dilated cardiomyopathy
52. Histopathology of familial versus nonfamilial dilated cardiomyopathy
53. The role of endomyocardial biopsy in the diagnosis of cardiac disorders in infants and children
54. Endomyocardial biopsy and the causes of dilated cardiomyopathy
55. The causes of dilated cardiomyopathy: A clinicopathologic review of 673 consecutive patients
56. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy
57. Correlations of antimyosin accumulation and histological manifestation of myocyte necrosis at different stages of idiopathic cardiomyopathy
58. Hypertrophic cardiomyopathy. Clinical spectrum and treatment
59. Altered distribution of desmin filaments in hypertrophic cardiomyopathy: An immunohistochemical study
60. Hypertrophic cardiomyopathy
61. Hypertrophic cardiomyopathy
62. Critical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy I: Morphological and morphometric aspects
63. Myocardial disarray: A critical review
64. The surgical pathology of hypertrophic cardiomyopathy
65. Myocardial catecholamines in primary heart muscle disease: Fact or fancy?
66. The pattern of desmin filaments in myocardial disarray
67. Myopathy and hypertrophic cardiomyopathy with selective lysis of thick filaments
68. Hypertrophic cardiomyopathy - Pathology and pathogenesis
69. Recent advances in the molecular genetics of hypertrophic cardiomyopathy
70. Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes
71. Role of molecular biology in identifying individual at risk for sudden cardiac death
72. Clinical profile and outcome of idiopathic restrictive cardiomyopathy
73. Clinical profile and outcome of restrictive cardiomyopathy in children
74. The cardiovascular manifestations of the hypereosinophilic syndrome: Prospective study of 26 patients, with review of the literature
75. Ultrastructural and immunohistochemical studies on myocardial biopsies from a patient with eosinophilic endomyocarditis
76. Improvement of eosinophilic heart disease after steroid therapy: Successful demonstration by endomyocardial biopsied specimens
77. Desmin myopathy involving cardiac, skeletal, and vascular smooth muscle: Report of a case with immunoelectron microscopy
78. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene
79. Electrocardiologie de quatre cas de dysplasie ventriculaire droite arythmogene
80. Arrhythmogenic right ventricular dysplasia: Dysplasia, dystrophy or myocarditis?
81. Characteristics and outcome in arrhythmogenic right ventricular dysplasia
82. Right ventricular dysplasia: The Mayo Clinic experience
83. Right ventricular dysplasia: A report of 24 adult cases
84. Right ventricular dysplasia associated with sudden death in young adults
85. Endomyocardial biopsy findings in patients with ventricular arrhythmias of unknown origin
86. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy
87. Endomyocardial biopsy in right ventricular dysplasia
88. Right ventricular dysplasia: Morphological findings in 13 cases
89. Right ventricular dysplasia: A clinical and pathological study of two families with left ventricular involvement
90. Arrhythmogenic right ventricular dysplasia with massive involvement of the left ventricle
91. Left ventricular involvement in right ventricular dysplasia
92. Histological abnormalities of the left ventricle in a patient with arrhythmogenic right ventricular dysplasia
93. Endomyocardial biopsy in arrhythmogenic right ventricular dysplasia
94. Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage
95. Is adipose tissue a normal component of the myocardium?
96. Potential role for endomyocardial biopsy in the clinical characterization of patients with idiopathic ventricular fibrillation: Arrhythmogenic right ventricular dysplasia - An undervalued cause